Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

44.01
-0.5500-1.23%
Post-market: 44.060.0500+0.11%19:01 EDT
Volume:6.58M
Turnover:291.49M
Market Cap:196.50B
PE:10.99
High:44.82
Open:44.60
Low:44.01
Close:44.56
52wk High:64.16
52wk Low:35.12
Shares:4.47B
Float Shares:3.19B
Volume Ratio:0.69
T/O Rate:0.21%
Dividend:1.72
Dividend Rate:3.91%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:6.03
PE(LYR):12.16

Loading ...

Novo Nordisk’s New Obesity Metabolism Trial: What Investors Should Watch

TIPRANKS
·
Aug 12

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 11

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
Aug 11

Eli Lilly's Foundayo Gains First European Approval, Igniting Global Oral Weight-Loss Drug Battle

Deep News
·
Aug 11

Cloud AI Today - Novo Nordisk Partners With AWS For AI-Driven Drug Discovery

Simply Wall St.
·
Aug 11

Novo Nordisk A/S Series B Stock Rises Monday, Outperforms Market

Dow Jones
·
Aug 11

Novo Nordisk Expands Treasury Position as 2026 Share Buyback Nears DKK 8 Billion

TIPRANKS
·
Aug 10

Novo Nordisk reports vesting of 100th Anniversary restricted shares to board and EVP

TIPRANKS
·
Aug 10

Novo Nordisk, Amazon Web Services Collaborate to Advance Drug Discovery for Chronic Diseases

MT Newswires Live
·
Aug 10

Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), Vanda (VNDA) and AbCellera Biologics (ABCL)

TIPRANKS
·
Aug 10

Analysts Have Conflicting Sentiments on These NA Companies: Novo Nordisk (GB:0QIU), Symrise (GB:0G6T) and Fraport AG Frankfurt Airport Services Worldwide (GB:0O1R)

TIPRANKS
·
Aug 08

Scholar Rock Holdings Pulls Novo Nordisk Facility from Drug Application After FDA Flag

Dow Jones
·
Aug 08

Analysts’ Opinions Are Mixed on These Healthcare Stocks: NRX Pharmaceuticals (NRXP), Novo Nordisk (NVO) and Pfizer (PFE)

TIPRANKS
·
Aug 08

Novo Nordisk A/S Series B Stock Rises Friday, Outperforms Market

Dow Jones
·
Aug 08

Update: Novo Nordisk Wins Dutch Injunction in Ceban Semaglutide Patent Case

MT Newswires Live
·
Aug 07

Movement Alert|Novo-Nordisk A/S Rises 3.15% in Regular Trading, Q2 Earnings Beat and Dutch Patent Victory Continue to Boost Sentiment

Market Focus
·
Aug 07

US Companies Face Rise in Cyber Attacks

Reuters
·
Aug 07

Novo Nordisk Results were Messy, Challenges Remain

Dow Jones
·
Aug 07

Movement Alert|Novo-Nordisk A/S Rises 3.09% in Pre-Market Trading, Q2 Earnings Beat and Dutch Patent Victory Continue to Lift Sentiment

Market Focus
·
Aug 07

Novo Nordisk (NVO) Faces A Fair Value Debate, Is It Still 55% Undervalued?

Simply Wall St.
·
Aug 07